Business Description
Bcworldpharm Co Ltd
ISIN : KR7200780005
Total Employee Number:
280Compare
Compare
Traded in other countries / regions
200780.Korea Index Membership
KOSDAQ Composite Index IPO Date
2014-12-15Description
Bcworldpharm Co Ltd is a pharmaceutical company. The company is engaged in research and develop new and improved drugs through R&D and technological innovation. The Company's products include Anti-TB, Anti-Diabetic, Analgesics, Narcotics Antidotes and Hemostatics.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.07 | |||||
Equity-to-Asset | 0.4 | |||||
Debt-to-Equity | 1.09 | |||||
Debt-to-EBITDA | 6.56 | |||||
Interest Coverage | 0.68 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 0.68 | |||||
Beneish M-Score | -2.64 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 5 | |||||
3-Year EBITDA Growth Rate | 5.3 | |||||
3-Year FCF Growth Rate | 57.8 | |||||
3-Year Book Growth Rate | -3.6 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 54.02 | |||||
9-Day RSI | 47.42 | |||||
14-Day RSI | 45.63 | |||||
3-1 Month Momentum % | -6.94 | |||||
6-1 Month Momentum % | -35.33 | |||||
12-1 Month Momentum % | -16.82 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.53 | |||||
Quick Ratio | 0.28 | |||||
Cash Ratio | 0.05 | |||||
Days Inventory | 156.73 | |||||
Days Sales Outstanding | 80.61 | |||||
Days Payable | 46.3 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 3.29 | |||||
3-Year Dividend Growth Rate | 6.6 | |||||
Forward Dividend Yield % | 3.29 | |||||
5-Year Yield-on-Cost % | 3.93 | |||||
Shareholder Yield % | 11.76 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 38 | |||||
Operating Margin % | 3.51 | |||||
Net Margin % | -3.61 | |||||
EBITDA Margin % | 14.41 | |||||
FCF Margin % | -0.74 | |||||
OCF Margin % | 5.9 | |||||
ROE % | -4.06 | |||||
ROA % | -1.66 | |||||
ROIC % | 1.36 | |||||
ROC (Joel Greenblatt) % | 2.36 | |||||
ROCE % | 3.94 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shiller PE Ratio | 43.87 | |||||
PS Ratio | 0.34 | |||||
PB Ratio | 0.45 | |||||
Price-to-Tangible-Book | 0.46 | |||||
Price-to-Operating-Cash-Flow | 5.77 | |||||
EV-to-EBIT | 30.84 | |||||
EV-to-EBITDA | 8.98 | |||||
EV-to-Revenue | 1.29 | |||||
EV-to-FCF | -173.68 | |||||
Price-to-GF-Value | 0.55 | |||||
Price-to-Projected-FCF | 1.25 | |||||
Price-to-Median-PS-Value | 0.15 | |||||
Earnings Yield (Greenblatt) % | 3.24 | |||||
FCF Yield % | -1.93 | |||||
Forward Rate of Return (Yacktman) % | -44.67 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bcworldpharm Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 80,328.107 | ||
| EPS (TTM) (â‚©) | -331.364 | ||
| Beta | 0.1385 | ||
| 3-Year Sharpe Ratio | -0.55 | ||
| 3-Year Sortino Ratio | -0.8 | ||
| Volatility % | 52.25 | ||
| 14-Day RSI | 45.63 | ||
| 14-Day ATR (â‚©) | 120.410655 | ||
| 20-Day SMA (â‚©) | 3051 | ||
| 12-1 Month Momentum % | -16.82 | ||
| 52-Week Range (â‚©) | 2795 - 6030 | ||
| Shares Outstanding (Mil) | 10.22 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bcworldpharm Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bcworldpharm Co Ltd Stock Events
| Event | Date | Price (â‚©) | ||
|---|---|---|---|---|
| KRW 100.000000 Cash Dividend | 2025-12-29 | 5,109.09 (+1.08%) | ||
| 1.1:1 Stock Split | 2025-12-29 | 5,109.09 (+1.08%) | ||
| KRW 90.909091 Cash Dividend | 2024-12-27 | 4,074.38 (+0.31%) | ||
| 1.1:1 Stock Split | 2024-12-27 | 4,074.38 (+0.31%) | ||
| 1.1:1 Stock Split | 2019-12-27 | 11,495.12 (-0.97%) | ||
| 1.1:1 Stock Split | 2017-12-27 | 16,187.42 (-0.42%) | ||
| 1.1:1 Stock Split | 2016-12-28 | 16,920.11 (-1.27%) |
Show
Entries
Bcworldpharm Co Ltd Frequently Asked Questions
What is Bcworldpharm Co Ltd(XKRX:200780)'s stock price today?
The current price of XKRX:200780 is â‚©3040.00. The 52 week high of XKRX:200780 is â‚©6030.00 and 52 week low is â‚©2795.00.
When is next earnings date of Bcworldpharm Co Ltd(XKRX:200780)?
The next earnings date of Bcworldpharm Co Ltd(XKRX:200780) is .
Does Bcworldpharm Co Ltd(XKRX:200780) pay dividends? If so, how much?
The Dividend Yield %  of Bcworldpharm Co Ltd(XKRX:200780) is 3.29% (As of Today), Highest Dividend Payout Ratio of Bcworldpharm Co Ltd(XKRX:200780) was 1.88. The lowest was 0.1. And the median was 0.15. The  Forward Dividend Yield % of Bcworldpharm Co Ltd(XKRX:200780) is 3.29%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers